DKL affiliate reports small insider stock sales

DKL affiliate reported recent small sales of common stock and scheduled vesting events.

Rhea-AI Filing Summary

DKL affiliate reported recent small sales of common stock and scheduled vesting events. The filing lists three completed sales of 250 shares each on 12/04/2025, 01/05/2026, and 02/04/2026 with gross proceeds of $11,465.00, $11,747.50, and $13,095.00 respectively. The record also shows restricted stock vesting entries dated 03/10/2023 (105 shares) and 12/10/2023 (145 shares).

Insights

Governance and Insider Transactions Analyst

Small, routine affiliate sales and prior restricted‑stock vesting are reported.

The excerpt documents three prior sales of 250 shares each with specific dates and gross proceeds: $11,465.00 on 12/04/2025, $11,747.50 on 01/05/2026, and $13,095.00 on 02/04/2026. These are discrete transactions by an affiliate (Reuven Spiegel) recorded in the Form 144 notice.

Dependencies and risks: timing and motivation for the sales are not stated and cash‑flow treatment beyond gross proceeds is not disclosed in the excerpt. Subsequent filings or broker records would be needed to assess whether additional sales are planned or part of a broader trading program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the DKL Form 144 report show?

The filing shows three completed sales of 250 shares each on 12/04/2025, 01/05/2026, and 02/04/2026 with gross proceeds listed as $11,465.00, $11,747.50, and $13,095.00 respectively.

Who is the selling affiliate named in the DKL filing?

The excerpt names Reuven Spiegel as the reporting affiliate with addresses shown and multiple sales recorded. The filing ties the sales to that individual’s reported transactions in the Form 144 entries.

Were any restricted stock vesting events disclosed for DKL?

Yes, the excerpt lists restricted stock vesting on 03/10/2023 for 105 shares and on 12/10/2023 for 145 shares, recorded as compensation‑related vesting entries.

Does the Form 144 state who received the sale proceeds?

The provided excerpt lists gross proceeds for each sale but does not specify who received the proceeds or how they were used; cash‑flow recipients are not disclosed in the excerpt.

Are the reported sales large relative to outstanding shares?

The excerpt reports small sales of 250 shares each; the filing does not provide a shares‑outstanding figure in the provided content, so relative size cannot be assessed from this excerpt alone.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 10:56 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001615515
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek Logistics Partners, LP
SEC File Number	001-35721
Address of Issuer	310 SEVEN SPRINGS WAY SUITE 500 BRENTWOOD TENNESSEE 37027
Phone	6157716701
Name of Person for Whose Account the Securities are To Be Sold	Spiegel Reuven
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	250	13300.00	53512343	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2023	Restricted Stock Vesting	Issuer			105	03/10/2023	Compensation
Common	12/10/2023	Restricted Stock Vesting	Issuer			145	12/10/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 02917	Common	12/04/2025	250	11465.00
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	01/05/2026	250	11747.50
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	02/04/2026	250	13095.00

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Reuven Spiegel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)